121 related articles for article (PubMed ID: 37119038)
21. Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
Wen X; Liu S; Cui M
Biomed Res Int; 2020; 2020():3598417. PubMed ID: 32685473
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.
Peng G; Dan W; Jun W; Junjun Y; Tong R; Baoli Z; Yang X
Tumour Biol; 2015 May; 36(5):3309-17. PubMed ID: 25586346
[TBL] [Abstract][Full Text] [Related]
24. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
25. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic Network Analysis Using Exfoliative Cervical Cells Could Discriminate a Potential Risk of Progression to Cancer in HPV-related Cervical Lesions: A Pilot Study.
Park NJ; Choi Y; Lee D; Park JY; Kim JM; Lee YH; Hong DG; Chong GO; Han HS
Cancer Genomics Proteomics; 2023; 20(1):75-87. PubMed ID: 36581343
[TBL] [Abstract][Full Text] [Related]
27. Identification of Differentially Expressed Genes in Cervical Cancer Patients by Comparative Transcriptome Analysis.
S D A; Pasumarthi D; Pasha A; Doneti R; B S; Botlagunta M; B VL; Pawar SC
Biomed Res Int; 2021; 2021():8810074. PubMed ID: 33829064
[TBL] [Abstract][Full Text] [Related]
28. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.
Cui H; Ma R; Hu T; Xiao GG; Wu C
Front Cell Infect Microbiol; 2022; 12():926348. PubMed ID: 35782114
[TBL] [Abstract][Full Text] [Related]
30. Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Mao Y; Fu Z; Dong L; Zheng Y; Dong J; Li X
DNA Cell Biol; 2019 Apr; 38(4):322-332. PubMed ID: 30698466
[TBL] [Abstract][Full Text] [Related]
31. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
32. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
33. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
34. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
[TBL] [Abstract][Full Text] [Related]
35. Screening of biomarkers in cervical squamous cell carcinomas via gene expression profiling.
Chen B; Li C; Zhang L; Lv J; Tong Y
Mol Med Rep; 2015 Nov; 12(5):6985-9. PubMed ID: 26398134
[TBL] [Abstract][Full Text] [Related]
36. CENPE, PRC1, TTK, and PLK4 May Play Crucial Roles in the Osteosarcoma Progression.
Wang F; Zhao Q; Liu W; Kong D
Technol Cancer Res Treat; 2020; 19():1533033820973278. PubMed ID: 33176597
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer.
Zhang YX; Zhao YL
Comput Math Methods Med; 2016; 2016():3186051. PubMed ID: 27034707
[TBL] [Abstract][Full Text] [Related]
38. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
39. Identification of biomarkers with a tumor stage-dependent expression and exploration of the mechanism involved in laryngeal squamous cell carcinoma.
Hui L; Yang N; Yang H; Guo X; Jang X
Oncol Rep; 2015 Nov; 34(5):2627-35. PubMed ID: 26323359
[TBL] [Abstract][Full Text] [Related]
40. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
